controlled porosity
FORMULATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC DRUG DELIVERY SYSTEM OF METOPROLOL SUCCINATE
... Controlled porosity osmotic tablet of metoprolol succinate prepared and evaluated in this study. Metoprolol succinate is very high soluble drug, so complete drug release obtained very fast. It is difficult ...
7
FORMULATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC DRUG DELIVERY SYSTEM OF METOPROLOL SUCCINATE
... Controlled porosity osmotic tablet of Metoprolol succinate prepared and evaluated in this study. Metoprolol succinate is very low soluble drug. So it is difficult to formulate osmotic tablet of Metoprolol ...
10
FORMULATION DEVELOPMENT AND EVALUATION OF CONTROLLED POROSITY OSMOTIC PUMP TABLET OF ATENOLOL
... a controlled release drug delivery system proceeds at a rate profile that is not only predictable kinetically but also reproducible from one unit to ...Activation controlled drug delivery system depends on ...
15
Formulation and evaluation of controlled porosity osmotic pump for oral delivery of valsartan
... Valsartan controlled Porosity Osmotic tablet was developed by doing Extensive literature survey. All The prepared Formulations of different and batches are evaluated for various pre compression & post ...
8
Development and evaluation of controlled porosity osmotic pump tablet of losartan potassium
... evaluate controlled porosity osmotic pump tablets of Losartan potassium to prolong the release of drug oral ...a controlled porosity osmotic pump tablet wit h ...
11
DEVELOPMENT AND EVALUATION OF SWELLABLE CONTROLLED POROSITY OSMOTIC PUMP TABLETS OF METOPROLOL SUCCINATE AND RAMIPRIL
... swellable controlled porosity osmotic pump tablets contained Metoprolol, Ramipril, mannitol (osmotic agent) PEO ,carbopol and PVAand SCMS (swellable polymer) surrounded by a semi permeable membrane CA with ...
19
FORMULATION AND CHARACTERIZATION OF CONTROLLED POROSITY OSMOTIC TABLETS OF ACYCLOVIR FOR TREATMENT OF HERPES SIMPLEX
... ABSTRACT: The main objective of present work was to formulate and evaluate swellable controlled porosity osmotic tablets of Acyclovir for the treatment of herpes simplex. This formulation aims to release ...
8
Formulation and stability studies of metformin hydrochloride in a controlled porosity osmotic pump system
... This study was designed to formulate, for the first time, metformin hydrochloride (MH, 850 mg/tablet) as a controlled porosity osmotic pump (CPOP) system to achieve zero-order release pattern. MH core ...
13
DEVELOPMENT AND IN-VITRO EVALUATION OF METOPROLOL SUCCINATE CONTROLLED POROSITY OSMOTIC PUMP TABLETS
... In vitro delivery of more than 90% of Metoprolol over 12 h with nearly constant zero-order release kinetics was success- fully achieved by optimization of the variables influencing the design of controlled ...
9
FORMULATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC PUMP TABLETS FOR ZIDOVUDINE AND LAMIVUDINE COMBINATION USING FRUCTOSE AS OSMOGEN
... The present study deals with the development and evaluation of controlled porosity osmotic pump (CPOP) tablets of Zidovudine– Lamivudine. Wet granulation method was used for the development of core tablets. ...
10
Effect of Polyethylene Glycol on Cellulose Acetate Films Designed for Controlled Porosity Osmotic Pump Systems
... a controlled porosity osmotic pump ...a controlled porosity osmotic pump ...properties, porosity, polarity and morphologies of the film were also ...
7
FORMULATION AND EVALUATION OF BACLOFEN CONTROLLED POROSITY OSMOTIC PUMP TABLETS
... by means of a laser beam. The rate at which the core absorbs water depends on the osmotic pressure generated by the core components and the permeability of the membrane coating. As the core absorbs water, it expands in ...
8
Formulation and Evaluation of Controlled Porosity Osmotic Tablets of Lornoxicam
... Department of Pharmaceutics, Madras Medical College Page 12 pump tablet by osmotic pressure and diffusion through pores created by the dissolution of pore formers incorporated in the membrane (Figure 1.6). The osmotic ...
149
FORMULATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC TABLETS OF LORNOXICAM
... evaluate controlled release formulation of lornoxicam based on osmotic ...from controlled porosity osmotic pump was directly proportional to the pore former (sorbitol) and level of osmogen ...
7
Use of a Naphthalene Based Binder in Injection Molding Net Shape Titanium Components of Controlled Porosity
... attributed to the low surface energies intrinsic to supercritical fluids. Consequently, as the fluid is removed through pores in the drying body, it exerts very little capillary or collapsing force on the remaining solid ...
7
Preparation of controlled porosity carbon aerogels for energy storage in rechargeable lithium oxygen batteries
... mesoporosity in carbons. The lower part of the hysteresis loops represent the filling of the mesopores while the upper parts rep- resent the emptying of the mesopores [13,14]. It can be observed that hystetesis loops for ...
8
DEVELOPMENT & EVALUATION OF PECTIN BASED CONTROLLED POROSITY OSMOTIC PUMP FOR COLONSPECIFIC DELIVERY SYSTEM
... A pectin based osmotic dosage form consisting of a enteric coated with a pH- dependent polymer is proposed for colonic specific delivery of drugs. Different approaches for colon-specific drug delivery have been studied ...
30
IN VIVO STUDIES & SEM OF CONTROLLED POROSITY OSMOTIC PUMP (CPOP) TABLET OF ATENOLOL
... The successful pharmaceutical development is the perfect understanding of the in- vivo and in – vitro performance of dosage form. In this study the drug release followed zero order kinetics independent of external ...
9
Protein Mediated Silica Particles with pH Controlled Porosity and Morphology
... the porosity variation in all biosynthesized silica particles prepared at different pH ...as porosity of the silica particles can be achievable by pH as an only ...
13
Development and evaluation of controlled porosity osmotic pump for Nifedipine and Metoprolol combination
... reported that smooth plasma profile of NP by modified release dosage forms decreased morbidity and mortality, prevents myocardial infarction in diabetes mellitus patients and reduces atherosclerosis in carotid and cor- ...
13